Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H S Silverman

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2017
Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional declineNare Torosyan, Kelsey Mason, Magnus Dahlbom, et al.
Seminars in Nuclear Medicine|June 3, 2008
Positron emission tomography scans obtained for the evaluation of cognitive dysfunctionDaniel H S Silverman, Lisa Mosconi, Linda Ercoli, et al.
Frontiers in Neurology|October 13, 2023
Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiologyL Brian Hickman, John M Stern, Daniel H S Silverman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2005
18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcomeAmy Tran, Betty S Pio, Bahareh Khatibi, et al.
Brain Imaging and Behavior|December 12, 2013
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future researchAndrew J Saykin, Michiel B de Ruiter, Brenna C McDonald, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain InjuryApril Alcantara, Gholam R Berenji, Carole S Scherling, et al.
Molecular Imaging and Biology|August 6, 2008
Radiation dose estimates for [18F]5-fluorouracil derived from PET-based and tissue-based methods in ratsAdam L Kesner, Wei-Ann Hsueh, Johannes Czernin, et al.
Biological Psychiatry|November 25, 2010
Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorderAndrea J Rapkin, Steven M Berman, Mark A Mandelkern, et al.
Chest|August 9, 2003
Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantationJean-Emmanuel Filmont, Johannes Czernin, Cecelia Yap, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2005
Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's diseaseXiao-Bo Pan, Thomas G Wright, F Joel Leong, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2017
Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional declineNare Torosyan, Kelsey Mason, Magnus Dahlbom, et al.
Seminars in Nuclear Medicine|June 3, 2008
Positron emission tomography scans obtained for the evaluation of cognitive dysfunctionDaniel H S Silverman, Lisa Mosconi, Linda Ercoli, et al.
Frontiers in Neurology|October 13, 2023
Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiologyL Brian Hickman, John M Stern, Daniel H S Silverman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2005
18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcomeAmy Tran, Betty S Pio, Bahareh Khatibi, et al.
Brain Imaging and Behavior|December 12, 2013
Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future researchAndrew J Saykin, Michiel B de Ruiter, Brenna C McDonald, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2019
Long-Term Clinical and Neuronuclear Imaging Sequelae of Cancer Therapy, Trauma, and Brain InjuryApril Alcantara, Gholam R Berenji, Carole S Scherling, et al.
Molecular Imaging and Biology|August 6, 2008
Radiation dose estimates for [18F]5-fluorouracil derived from PET-based and tissue-based methods in ratsAdam L Kesner, Wei-Ann Hsueh, Johannes Czernin, et al.
Biological Psychiatry|November 25, 2010
Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorderAndrea J Rapkin, Steven M Berman, Mark A Mandelkern, et al.
Chest|August 9, 2003
Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantationJean-Emmanuel Filmont, Johannes Czernin, Cecelia Yap, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2005
Improving influx constant and ratio estimation in FDOPA brain PET analysis for Parkinson's diseaseXiao-Bo Pan, Thomas G Wright, F Joel Leong, et al.
Pageof 6